Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest of ENZO BIOCHEM INC from 31 Jul 2010 to 30 Apr 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary: ENZO BIOCHEM INC quarterly and annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD history and change rate from 31 Jul 2010 to 30 Apr 2025.
ENZO BIOCHEM INC Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending 30 Apr 2025 was $2,374,000, a 11% decline year-over-year.
ENZO BIOCHEM INC Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending 30 Apr 2025 was $7,841,000, a 55% increase year-over-year.
ENZO BIOCHEM INC annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2024 was $9,817,000, a 61% increase from 2023.
ENZO BIOCHEM INC annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was $25,022,000, a 23% decline from 2022.
ENZO BIOCHEM INC annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was $20,339,000, a 358% decline from 2021.
Source SEC data: View on sec.gov

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Change (%)

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Change (%)

ENZO BIOCHEM INC Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$7,841,000	$2,374,000	-$243,000	-11%	01 Feb 2025	30 Apr 2025	10-Q	16 Jun 2025	2025	Q3
Q4 2024	$7,598,000	$1,248,000	-$385,000	-45%	01 Nov 2024	31 Jan 2025	10-Q	17 Mar 2025	2025	Q2
Q3 2024	$7,213,000	$3,071,000	+$2,604,000	+46%	01 Aug 2024	31 Oct 2024	10-Q	16 Dec 2024	2025	Q1
Q2 2024	$9,817,000	$1,148,000	+$7,731,000	+87%	01 May 2024	31 Jul 2024	10-K	29 Oct 2024	2024	FY
Q1 2024	$17,548,000	$2,131,000	+$5,766,000	+73%	01 Feb 2024	30 Apr 2024	10-Q	16 Jun 2025	2025	Q3
Q4 2023	$23,314,000	$863,000	+$2,029,000	+70%	01 Nov 2023	31 Jan 2024	10-Q	17 Mar 2025	2025	Q2
Q3 2023	$25,343,000	$5,675,000	-$321,000	-6%	01 Aug 2023	31 Oct 2023	10-Q	16 Dec 2024	2025	Q1
Q2 2023	$25,022,000	$8,879,000			01 May 2023	31 Jul 2023	10-K	29 Oct 2024	2024	FY
Q1 2023		$7,897,000	-$3,043,000	-63%	01 Feb 2023	30 Apr 2023	10-Q	13 Jun 2024	2024	Q3
Q4 2022		$2,892,000	-$237,000	-8.9%	01 Nov 2022	31 Jan 2023	10-Q	13 Mar 2024	2024	Q2
Q3 2022		$5,354,000			01 Aug 2022	31 Oct 2022	10-Q	15 Dec 2023	2024	Q1
Q1 2022		$4,854,000	-$6,860,000	-342%	01 Feb 2022	30 Apr 2022	10-Q	14 Jun 2023	2023	Q3
Q4 2021		$2,655,000	-$4,957,000	-215%	01 Nov 2021	31 Jan 2022	10-Q	20 Mar 2023	2023	Q2
Q1 2021		$2,006,000	+$11,866,000		01 Feb 2021	30 Apr 2021	10-Q	09 Jun 2022	2022	Q3
Q4 2020		$2,302,000	+$9,989,000		01 Nov 2020	31 Jan 2021	10-Q	14 Mar 2022	2022	Q2
Q2 2020	$28,520,000	$3,325,000	+$2,062,000	+38%	01 May 2020	31 Jul 2020	10-K	14 Oct 2022	2022	FY
Q1 2020	$30,582,000	$9,860,000	-$32,125,000	-144%	01 Feb 2020	30 Apr 2020	10-Q	11 Jun 2021	2021	Q3
Q4 2019	$1,543,000	$7,687,000	+$721,000	+8.6%	01 Nov 2019	31 Jan 2020	10-Q	16 Mar 2021	2021	Q2
Q3 2019	$822,000	$7,648,000	-$1,667,000	-28%	01 Aug 2019	31 Oct 2019	10-Q	10 Dec 2019	2019	Q1
Q2 2019	$2,489,000	$5,387,000	+$377,000	+6.5%	01 May 2019	31 Jul 2019	10-K	12 Oct 2021	2021	FY
Q1 2019	$2,112,000	$22,265,000	+$25,281,000		01 Feb 2019	30 Apr 2019	10-Q	10 Jun 2019	2019	Q3
Q4 2018	$23,169,000	$8,408,000	-$6,410,000	-321%	01 Nov 2018	31 Jan 2019	10-Q	06 Mar 2020	2020	Q2
Q3 2018	$16,759,000	$5,981,000	-$5,341,000	-835%	01 Aug 2018	31 Oct 2018	10-Q	10 Dec 2019	2019	Q1
Q2 2018	$11,418,000	$5,764,000	-$5,835,000	-8218%	01 May 2018	31 Jul 2018	10-K	19 Oct 2020	2020	FY
Q1 2018	$5,583,000	$3,016,000	-$2,945,000	-4148%	01 Feb 2018	30 Apr 2018	10-Q	10 Jun 2019	2019	Q3
Q4 2017	$2,638,000	$1,998,000	-$945,000	-90%	01 Nov 2017	31 Jan 2018	10-Q	11 Mar 2019	2019	Q2
Q3 2017	$1,693,000	$640,000	+$834,000	+57%	01 Aug 2017	31 Oct 2017	10-Q	10 Dec 2018	2019	Q1
Q2 2017	$2,527,000	$71,000	-$36,997,000	-100%	01 May 2017	31 Jul 2017	10-K	27 Sep 2017	2017	FY
Q1 2017	$34,470,000	$71,000	+$2,042,000	+97%	01 Feb 2017	30 Apr 2017	10-Q	11 Jun 2018	2018	Q3
Q4 2016	$32,428,000	$1,053,000	-$8,092,000	-115%	01 Nov 2016	31 Jan 2017	10-Q	12 Mar 2018	2018	Q2
Q3 2016	$40,520,000	$1,474,000	-$5,995,000	-133%	01 Aug 2016	31 Oct 2016	10-Q	07 Dec 2017	2018	Q1
Q2 2016	$46,515,000	$37,068,000	+$28,545,000	+335%	01 May 2016	31 Jul 2016	10-K	27 Sep 2017	2017	FY
Q1 2016	$17,970,000	$2,113,000	+$890,000	+30%	01 Feb 2016	30 Apr 2016	10-K	27 Sep 2017	2017	FY
Q4 2015	$17,080,000	$7,039,000	+$11,245,000		01 Nov 2015	31 Jan 2016	10-K	27 Sep 2017	2017	FY
Q3 2015	$5,835,000	$4,521,000	+$8,127,000		01 Aug 2015	31 Oct 2015	10-K	27 Sep 2017	2017	FY
Q2 2015	$2,292,000	$8,523,000	+$11,685,000		01 May 2015	31 Jul 2015	10-K	13 Oct 2016	2016	FY
Q1 2015	$13,977,000	$3,003,000	-$2,555,000	-570%	01 Feb 2015	30 Apr 2015	10-K	13 Oct 2016	2016	FY
Q4 2014	$11,422,000	$4,206,000	-$636,000	-18%	01 Nov 2014	31 Jan 2015	10-K	13 Oct 2016	2016	FY
Q3 2014	$10,786,000	$3,606,000	-$881,000	-32%	01 Aug 2014	31 Oct 2014	10-K	13 Oct 2016	2016	FY
Q2 2014	$9,905,000	$3,162,000	+$370,000	+10%	01 May 2014	31 Jul 2014	10-K	13 Oct 2015	2015	FY
Q1 2014	$10,275,000	$448,000	+$5,360,000	+92%	01 Feb 2014	30 Apr 2014	10-K	13 Oct 2015	2015	FY
Q4 2013	$15,635,000	$3,570,000	+$2,284,000	+39%	01 Nov 2013	31 Jan 2014	10-K	13 Oct 2015	2015	FY
Q3 2013	$17,919,000	$2,725,000	+$1,030,000	+27%	01 Aug 2013	31 Oct 2013	10-K	13 Oct 2015	2015	FY
Q2 2013	$18,949,000	$3,532,000	+$25,542,000	+88%	01 May 2013	31 Jul 2013	10-K	09 Oct 2014	2014	FY
Q1 2013	$44,491,000	$5,808,000	-$2,363,000	-69%	01 Feb 2013	30 Apr 2013	10-K	09 Oct 2014	2014	FY
Q4 2012	$42,128,000	$5,854,000	-$1,778,000	-44%	01 Nov 2012	31 Jan 2013	10-K	09 Oct 2014	2014	FY
Q3 2012	$40,350,000	$3,755,000	+$571,000	+13%	01 Aug 2012	31 Oct 2012	10-K	09 Oct 2014	2014	FY
Q2 2012	$40,921,000	$29,074,000	-$24,875,000	-592%	01 May 2012	31 Jul 2012	10-K	15 Oct 2013	2013	FY
Q1 2012	$16,046,000	$3,445,000	-$1,443,000	-72%	01 Feb 2012	30 Apr 2012	10-K	15 Oct 2013	2013	FY
Q4 2011	$14,603,000	$4,076,000	+$1,486,000	+27%	01 Nov 2011	31 Jan 2012	10-K	15 Oct 2013	2013	FY
Q3 2011	$16,089,000	$4,326,000	-$3,266,000	-308%	01 Aug 2011	31 Oct 2011	10-K	15 Oct 2013	2013	FY
Q2 2011	$12,823,000	$4,199,000			01 May 2011	31 Jul 2011	10-K	15 Oct 2012	2012	FY
Q1 2011		$2,002,000			01 Feb 2011	30 Apr 2011	10-K	15 Oct 2012	2012	FY
Q4 2010		$5,562,000			01 Nov 2010	31 Jan 2011	10-K	15 Oct 2012	2012	FY
Q3 2010		$1,060,000			01 Aug 2010	31 Oct 2010	10-K	15 Oct 2012	2012	FY

ENZO BIOCHEM INC Annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$9,817,000	+$15,205,000	+61%	01 Aug 2023	31 Jul 2024	10-K	29 Oct 2024	2024	FY
2023	$25,022,000	-$4,683,000	-23%	01 Aug 2022	31 Jul 2023	10-K	29 Oct 2024	2024	FY
2022	$20,339,000	-$28,214,000	-358%	01 Aug 2021	31 Jul 2022	10-K	03 Nov 2023	2023	FY
2021	$7,875,000	+$36,395,000		01 Aug 2020	31 Jul 2021	10-K	14 Oct 2022	2022	FY
2020	$28,520,000	-$31,009,000	-1246%	01 Aug 2019	31 Jul 2020	10-K	14 Oct 2022	2022	FY
2019	$2,489,000	+$13,907,000		01 Aug 2018	31 Jul 2019	10-K	12 Oct 2021	2021	FY
2018	$11,418,000	-$8,914,000	-356%	01 Aug 2017	31 Jul 2018	10-K	19 Oct 2020	2020	FY
2017	$2,504,000	-$48,864,000	-105%	01 Aug 2016	31 Jul 2017	10-K	15 Oct 2019	2019	FY
2016	$46,360,000	+$48,652,000		01 Aug 2015	31 Jul 2016	10-K	15 Oct 2018	2018	FY
2015	$2,292,000	+$7,613,000	+77%	01 Aug 2014	31 Jul 2015	10-K	27 Sep 2017	2017	FY
2014	$9,905,000	+$9,044,000	+48%	01 Aug 2013	31 Jul 2014	10-K	13 Oct 2016	2016	FY
2013	$18,949,000	+$21,972,000	+54%	01 Aug 2012	31 Jul 2013	10-K	13 Oct 2015	2015	FY
2012	$40,921,000	-$28,098,000	-219%	01 Aug 2011	31 Jul 2012	10-K	09 Oct 2014	2014	FY
2011	$12,823,000	+$9,438,000	+42%	01 Aug 2010	31 Jul 2011	10-K	15 Oct 2013	2013	FY
2010	$22,261,000			01 Aug 2009	31 Jul 2010	10-K	15 Oct 2012	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.